KYMR
Kymera Therapeutics, Inc. · Healthcare
Director Bruce Booth sold $3.4M of Kymera Therapeutics, Inc.
Sold$3,424,800
$109.48Price
31,283Shares
−6%Stake
What KYMR did after the filing
- The stock from Wed, Jul 1 open, $114.29
- +0.1%
- S&P 500, same days
- +4.4%
Measured over 30 trading days, to the Aug 13 close.
Traded Mon, Jun 29. Filed Tue, Jun 30, 5:32 PM ET, after the close. Returns use the Jul 1 open and the Aug 13 close. Not investment advice.